Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Operating Leases (2019 - 2025)

Nutex Health's Operating Leases history spans 7 years, with the latest figure at $30.0 million for Q4 2025.

  • For Q4 2025, Operating Leases fell 1.89% year-over-year to $30.0 million; the TTM value through Dec 2025 reached $30.0 million, down 1.89%, while the annual FY2025 figure was $30.0 million, 1.89% down from the prior year.
  • Operating Leases for Q4 2025 was $30.0 million at Nutex Health, down from $30.4 million in the prior quarter.
  • Across five years, Operating Leases topped out at $56.9 million in Q3 2021 and bottomed at $79659.0 in Q2 2021.
  • The 5-year median for Operating Leases is $19.7 million (2022), against an average of $21.3 million.
  • The largest YoY upside for Operating Leases was 31140.81% in 2021 against a maximum downside of 68.06% in 2021.
  • A 5-year view of Operating Leases shows it stood at $20.8 million in 2021, then fell by 6.64% to $19.4 million in 2022, then decreased by 20.37% to $15.5 million in 2023, then skyrocketed by 97.79% to $30.6 million in 2024, then decreased by 1.89% to $30.0 million in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Operating Leases are $30.0 million (Q4 2025), $30.4 million (Q3 2025), and $30.8 million (Q2 2025).